Amazon India's 9th Prime Day returns this July with big deals, perks

Amazon India on Wednesday announced the return of its highly-awaited Prime Day event this July, which marks the 9th instalment of the shopping bonanza that offers substantial discounts on consumer goods.
The event promises some of the biggest deals of the summer across categories such as electronics, beauty products, kitchen essentials, and fashion for subscribers of Amazon's premium service 'Prime'.
"We are excited to announce that Amazon.in's 9th Prime Day event is coming in July. Prime members can look forward to some of Amazon's best deals of the summer during Prime Day 2025. We're offering members discounts on some of the hottest brands, socially trending items, creator favorites, and Amazon-exclusive products to make this July's event even more valuable for members," the company said in a statement.
As part of their subscription, Prime members will be able to take advantage of exclusive offers by Amazon sellers across all categories.
Currently, Prime members in India enjoy unlimited free same-day delivery on over a million products, next-day delivery on more than four million items, and ultra-fast four-hour delivery on more than 20,000 products.
"We know members love savings, so we are working hard to offer the best deals from both new & existing brands and sellers," the company said.
Participating countries in the event
Besides India, Prime Day 2025 will return to the following countries this year: Australia, Austria, Belgium, Brazil, Canada, Egypt, France, Germany, Italy, Japan, Luxembourg, Mexico, the Netherlands, Poland, Portugal, Saudi Arabia, Singapore, Spain, Sweden, Turkey, the United Arab Emirates, the US, and the UK.
Prime Day 2024
Last year's Prime Day in India set new records, with the highest sales ever and more items sold than during any previous edition of the event.
During Prime Day 2024, independent small and medium businesses (SMBs) in India achieved record-breaking sales, with a more than 30 per cent year-on-year increase. SMBs — including women entrepreneurs, weavers, and artisans — sold over 1,600 units every minute, marking the highest participation across all editions.
In 2024, Amazon India also achieved a major milestone by delivering at its fastest speeds ever for Prime members, fulfilling over 41 crore orders with same-day or next-day delivery.
Globally, Prime members saved nearly $95 billion through fast and free delivery benefits, the company said. In India, members saved an average of over ₹3,300 on deliveries in the past year, more than double the cost of a yearly Prime membership.

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Time of India

an hour ago

• Time of India

Amazon launches home diagnostic services in 6 cities through app

Amazon India on Sunday announced the launch of Amazon Diagnostics, an at-home service for customers to book lab tests, schedule and track appointments, and access digital reports through the Amazon app. The service, being offered in collaboration with Orange Health Labs , will be available in Bengaluru, Delhi, Gurgaon, Noida, Mumbai, and Hyderabad, across over 450 PIN codes, the company said in a statement. With this addition, Amazon has now integrated its existing pharmacy and clinic services under Amazon Medical . "This expansion strengthens the foundation of Amazon Medical by building on the existing service of Pharmacy and Clinic. With Amazon Pharmacy , customers get access to a wide range of prescription medications and healthcare essentials, along with a free telemedicine consultation service and delivery benefits for Prime and non-Prime members. Amazon Clinic enables customers to consult licensed doctors for a range of primary healthcare needs through a seamless digital experience," Amazon said. Amazon Diagnostics will offer over 800 diagnostic tests and doorstep sample collection within 60 minutes.

Economic Times

2 hours ago

• Economic Times

Dr Lal PathLabs, Metropolis, other diagnostic stocks fall up to 3% after Amazon launches home testing service

Shares of diagnostics companies declined on Monday after Amazon India announced the launch of home diagnostics services across six major cities. ADVERTISEMENT Dr Lal PathLabs and Metropolis fell up to 3% in early trade. Krsnaa Diagnostics slipped 2.2%, Thyrocare Technologies was down nearly 1%, and Suraksha Diagnostic dipped 0.5% on the BSE. The pressure followed Amazon India's announcement on Sunday about the rollout of Amazon Diagnostics, an at-home lab testing service that allows users to book tests, schedule and track sample collection, and access digital reports via the Amazon app. The service, in collaboration with Orange Health Labs, will be available in Bengaluru, Delhi, Gurgaon, Noida, Mumbai, and Hyderabad, covering over 450 PIN codes. Also Read: Why stock market is falling today? Key factors behind 900-point Sensex crash, Nifty below 24,850 Amazon has integrated this new offering with its existing health services — Amazon Pharmacy and Amazon Clinic — under the Amazon Medical banner. ADVERTISEMENT "This expansion strengthens the foundation of Amazon Medical by building on the existing service of Pharmacy and Clinic. With Amazon Pharmacy, customers get access to a wide range of prescription medications and healthcare essentials, along with a free telemedicine consultation service and delivery benefits for Prime and non-Prime members. Amazon Clinic enables customers to consult licensed doctors for a range of primary healthcare needs through a seamless digital experience," Amazon Diagnostics will offer over 800 diagnostic tests and doorstep sample collection within 60 minutes. ADVERTISEMENT Also Read: Is the grey market premium misleading? Decoding the valuation gap in HDB Financial's IPO The tech giant's entry into diagnostics adds competition for established players, triggering investor concerns and weighing on stock prices. Also Read: 11 Nifty mid & smallcap stocks that can rally 40-90% over the next 12 months (Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of the Economic Times) (You can now subscribe to our ETMarkets WhatsApp channel)

Time of India

2 hours ago

• Time of India

Dr Lal PathLabs, Metropolis, other diagnostic stocks fall up to 3% after Amazon launches home testing service

Shares of diagnostics companies declined on Monday after Amazon India announced the launch of home diagnostics services across six major cities. Dr Lal PathLabs and Metropolis fell up to 3% in early trade. Krsnaa Diagnostics slipped 2.2%, Thyrocare Technologies was down nearly 1%, and Suraksha Diagnostic dipped 0.5% on the BSE. The pressure followed Amazon India's announcement on Sunday about the rollout of Amazon Diagnostics , an at-home lab testing service that allows users to book tests, schedule and track sample collection, and access digital reports via the Amazon app. The service, in collaboration with Orange Health Labs, will be available in Bengaluru, Delhi, Gurgaon, Noida, Mumbai, and Hyderabad, covering over 450 PIN codes. Also Read: Why stock market is falling today? Key factors behind 900-point Sensex crash, Nifty below 24,850 Amazon has integrated this new offering with its existing health services — Amazon Pharmacy and Amazon Clinic — under the Amazon Medical banner. "This expansion strengthens the foundation of Amazon Medical by building on the existing service of Pharmacy and Clinic. With Amazon Pharmacy, customers get access to a wide range of prescription medications and healthcare essentials, along with a free telemedicine consultation service and delivery benefits for Prime and non-Prime members. Amazon Clinic enables customers to consult licensed doctors for a range of primary healthcare needs through a seamless digital experience," Amazon said. Amazon Diagnostics will offer over 800 diagnostic tests and doorstep sample collection within 60 minutes. Also Read: Is the grey market premium misleading? Decoding the valuation gap in HDB Financial's IPO The tech giant's entry into diagnostics adds competition for established players, triggering investor concerns and weighing on stock prices. Also Read: 11 Nifty mid & smallcap stocks that can rally 40-90% over the next 12 months ( Disclaimer : Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of the Economic Times)